Roland v. Green’s Empirical Analysis
675 F.3d 503 · 2012
Citation profile
5 federal appellate ·
Relationships
Applies 15 U.S.C. § 77R (§ 18 of the Securities Act of 1933) · 15 U.S.C. § 78B (§ 2 of the Securities Exchange Act of 1934) · 15 U.S.C. § 78U (§ 21d of the Securities Exchange Act of 1934) · 28 U.S.C. § 1332 (Class Action Fairness Act of 2005)
Relies on Blue Chip Stamps v. Manor Drug Stores · Superintendent of Insurance of State of New York v. Bankers Life and Casualty Company · Merrill Lynch, Pierce, Fenner & Smith Inc. v. Dabit · United States v. O'Hagan · Securities & Exchange Commission v. Zandford
Most-quoted passages
The sentences later courts lift from this opinion, ranked by how many decisions quote each — the parts of the opinion doing the work. These counts are smaller than the citation total above because most of the 13 citing decisions cite the case generally; a passage count includes only decisions quoting that exact language verbatim.
“misrepresentation or omission of a material fact in connection with the purchase or sale of a covered security.”
3 later decisions quote this exact passage · from the majority“'traded nationally [or] listed on a regulated national exchange.' " App. to Pet. for Cert. in No. 12-86, p. 62. But each complaint in one way or another alleged that the fraud included misrepresentations that the Bank maintained significant holdings in " 'highly marketable securities issued by stable governments [and] strong multinational companies,' " and that the Bank's ownership of these "covered”
2 later decisions quote this exact passage · from the majority“§ 78bb(f)(1)(A). How broad is that scope? Does it extend further than misrepresentations that are material to the purchase or sale of a covered security? In our view, the scope of this language does not extend further. To put the matter more specifically: A fraudulent misrepresentation or omission is not made”
2 later decisions quote this exact passage · from the majority
How this case has been treated — in progress
Whether each later court followed, distinguished, criticized, or overruled this decision. The treatment classification (task #35) runs highest-cited cases first and lights up here as it reaches this one.